Search research articles
Contact Us
Filters
Showing results (151-160 of 183) with videos related to
Page
of 19
Sort By:
Virchows Archiv : an International Journal of Pathology
|
May 18, 2023
Implementation of circulating tumour DNA multi-target mutation testing in plasma: a perspective from an external quality assessment providers' survey
Jennifer A Fairley, Tony Badrick, Marc G Denis, et al.
Cancer Research
|
October 26, 2010
Zoledronic acid potentiates mTOR inhibition and abolishes the resistance of osteosarcoma cells to RAD001 (Everolimus): pivotal role of the prenylation process
Gatien Moriceau, Benjamin Ory, Laura Mitrofan, et al.
Respiratory Research
|
April 5, 2024
Use of non-small cell lung cancer multicellular tumor spheroids to study the impact of chemotherapy
Pauline Hulo, Sophie Deshayes, Judith Fresquet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2000
Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction
P de Cremoux, J M Extra, M G Denis, et al.
ESMO Open
|
February 24, 2022
Recommendations for a practical implementation of circulating tumor DNA mutation testing in metastatic non-small-cell lung cancer
E Heitzer, D van den Broek, M G Denis, et al.
Annales De Dermatologie Et De Venereologie
|
August 17, 2016
[Update to the recommendations for management of melanoma stages I to III]
B Guillot, S Dalac, M G Denis, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 26, 2017
French updated recommendations in Stage I to III melanoma treatment and management
B Guillot, S Dalac, M G Denis, et al.
Experimental Dermatology
|
May 20, 2016
Clinical significance of BRAF mutation status in circulating tumor DNA of metastatic melanoma patients at baseline
Anne C Knol, Audrey Vallée, Guillaume Herbreteau, et al.
Plos One
|
March 20, 2015
Detection of BRAF V600 mutations in melanoma: evaluation of concordance between the Cobas® 4800 BRAF V600 mutation test and the methods used in French National Cancer Institute (INCa) platforms in a real-life setting
Samia Mourah, Marc G Denis, Fabienne Escande Narducci, et al.
Molecular Metabolism
|
November 1, 2019
New roles for prokineticin 2 in feeding behavior, insulin resistance and type 2 diabetes: Studies in mice and humans
Marie Mortreux, Ewout Foppen, Raphaël G Denis, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 183) with videos related to
Sort By:
Page
of 19
Virchows Archiv : an International Journal of Pathology
|
May 18, 2023
Implementation of circulating tumour DNA multi-target mutation testing in plasma: a perspective from an external quality assessment providers' survey
Jennifer A Fairley, Tony Badrick, Marc G Denis, et al.
Cancer Research
|
October 26, 2010
Zoledronic acid potentiates mTOR inhibition and abolishes the resistance of osteosarcoma cells to RAD001 (Everolimus): pivotal role of the prenylation process
Gatien Moriceau, Benjamin Ory, Laura Mitrofan, et al.
Respiratory Research
|
April 5, 2024
Use of non-small cell lung cancer multicellular tumor spheroids to study the impact of chemotherapy
Pauline Hulo, Sophie Deshayes, Judith Fresquet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2000
Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction
P de Cremoux, J M Extra, M G Denis, et al.
ESMO Open
|
February 24, 2022
Recommendations for a practical implementation of circulating tumor DNA mutation testing in metastatic non-small-cell lung cancer
E Heitzer, D van den Broek, M G Denis, et al.
Annales De Dermatologie Et De Venereologie
|
August 17, 2016
[Update to the recommendations for management of melanoma stages I to III]
B Guillot, S Dalac, M G Denis, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 26, 2017
French updated recommendations in Stage I to III melanoma treatment and management
B Guillot, S Dalac, M G Denis, et al.
Experimental Dermatology
|
May 20, 2016
Clinical significance of BRAF mutation status in circulating tumor DNA of metastatic melanoma patients at baseline
Anne C Knol, Audrey Vallée, Guillaume Herbreteau, et al.
Plos One
|
March 20, 2015
Detection of BRAF V600 mutations in melanoma: evaluation of concordance between the Cobas® 4800 BRAF V600 mutation test and the methods used in French National Cancer Institute (INCa) platforms in a real-life setting
Samia Mourah, Marc G Denis, Fabienne Escande Narducci, et al.
Molecular Metabolism
|
November 1, 2019
New roles for prokineticin 2 in feeding behavior, insulin resistance and type 2 diabetes: Studies in mice and humans
Marie Mortreux, Ewout Foppen, Raphaël G Denis, et al.
Page
of 19